Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
life sciences
national blog main
national top stories
biotech
boston blog main
boston top stories
clinical trials
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
abbvie
acorda therapeutics
acute myeloid leukemia
adverum biotechnologies
alder biopharmaceuticals
ambit biosciences
amgen
ampyra
apokyn
apomorphine
athena countouriotis
boulder/denver blog main
boulder/denver top stories
brett zbar
bristol-myers squibb
calcitonin gene-related peptide
chronic migraine
cormorant asset management
daiichi sankyo
dalfampridine
david rind
detroit blog main
detroit top stories
duopa
eli lilly
episodic migraine
eptinezumab
erenumab
What
drug
3
×
gets
3
×
new
3
×
fda
nod
acorda
amgen
approval
approved
athena
biotech
cancer
candidates
ceo
chief
class
cope
countouriotis
developed
disease
episodes
financing
friday
head
help
late
looms
meant
medical
medications
medicines
mezzanine
migraine
million
names
officer
old
pain
parkinson’s
patients
Language
Current search:
gets
×
new
×
photo
×
drug
×
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines